PULSE BIOSCIENCES, INC. — Director's Dealing 2023

Jun 16, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-06-14

Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-14	Common Stock	X	5683163	$2.05	Acquired	36097824	Direct
2023-06-14	Common Stock	X	81025	$2.05	Acquired	492069	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-14	Warrant (right to buy)	$2.05	X	5683163	Disposed	2027-06-09	Common Stock (5683163)	Direct
2023-06-14	Warrant (right to buy)	$2.05	X	81025	Disposed	2027-06-09	Common Stock (81025)	Indirect

Footnotes

F1: Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.